Recent News

By Category: Research

House votes to cut KBA role in funding of NBAF bio lab

TOPEKA, Kan. — The Kansas House has approved a bill ending the Kansas Bioscience Authority’s role in issuing state bonds to help finance a new national biodefense lab in Manhattan. Wednesday’s 123-0 vote sends the measure to the Senate. The bill comes amid criticism of the Bioscience Authority’s operations and an investigation by the Johnson Read More »

May 12, 2011
| Filed under Policy & Initiatives and Research
Share

Cattlemen Claim Laws Broken in Siting Bio Lab

FOOD SAFETY NEWS — Mysterious animal research that has long gone on at Plum Island is suppose to be transferred to a new National Bio and Agro-Defense Facility to be built in the middle of cattle country in Manhattan, KS. But a criminal inquiry into a group credited with attracting the bio-defense facility to Kansas Read More »

May 11, 2011
| Filed under North America, Biosafety, and Research
Share

Anatomy of an outbreak

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON — Researchers have found a genetic solution to the puzzle of why the chikungunya virus infected millions of people after it was introduced to Asia in 2005 but infected almost no one after an earlier Asian introduction.

May 10, 2011
| Filed under Asia/Pacific and Research
Share

Foot-and-mouth disease study could save millions of animals

USA TODAY — A paper out today in the journal Science could save the lives of millions of cattle, sheep, goats and pigs. Researchers in the United Kingdom have proven that the infectious period for foot-and-mouth disease is only 1.7 days on average, rather than the four to eight days previously believed. That number means Read More »

May 9, 2011
| Filed under North America, Agents & Toxins, Agriculture, and Research
Share

UCSF Botulism Research Translates Into Bioterrorism Treatment

UCSF NEWS – UCSF basic research into botulism has translated into a novel antitoxin to protect against bioterrorism, with the first clinical trials launching soon to assess the resulting vaccine’s safety. This first-ever recombinant human therapy to target the deadly Clostridium botulinum neurotoxin could serve both to treat poisoning and protect against it for six Read More »